Gd-DTPA-enhanced MR imaging of pituitary adenomas

Eleven previously nonoperated patients with suspected pituitary microadenomas were scanned on a 1.5-T GE system before and after administration of IV gadolinium-DTPA (0.1 mmol/kg). Six patients had Cushing disease, four had hyperprolactinemia, and one had acromegaly. Surgical confirmation was available in all cases, and these findings were correlated with results of CT and venous sampling, when available. The normal pituitary gland, infundibulum, and cavernous sinuses enhance immediately after the administration of gadolinium-DTPA, allowing contrast between the enhancing normal glandular tissue and low-intensity microadenomas. Contrast-enhanced MR detected a lesion not seen on the unenhanced images in two patients with Cushing disease and in one patient with hyperprolactinemia. Tumor delineation was improved with gadolinium administration in two additional cases. In six patients, administration of gadolinium did not significantly alter the precontrast interpretation. Adenomas were found at surgery in all 11 patients. The tumor was correctly localized on MR in four of the six patients with Cushing disease, resulting in an accuracy of 66.7%. In another patient, although a focal lesion was detected on MR, location of the adenoma at surgery was discrepant with the MR findings and was therefore considered a false-positive study. In the single false-negative examination, both pre- and postcontrast MR failed to detect a surgically confirmed microadenoma suspected on both contrast-enhanced CT and venous sampling. Correct localization of the adenoma was achieved in all of the five non-Cushing patients, yielding an accuracy of 100%. Immediate T1-weighted coronal scans were most useful in detecting intrasellar disease. Delayed scans obtained 30 min after injection did not improve the differentiation of pituitary gland from microadenoma.(ABSTRACT TRUNCATED AT 250 WORDS)     

MR imaging of intrasellar meningiomas simulating pituitary adenomas

Over 3 1/2 years, 401 magnetic resonance studies were performed for suspected sellar-parasellar masses. Twenty-nine pituitary macroadenomas and 12 meningiomas were detected. Among the meningiomas there were three whose MR appearance simulated that of a pituitary tumor. In none of these cases was the diaphragma sellae visualized. Furthermore, in one case the prolactin level was elevated. A preoperative diagnosis of pituitary tumor resulted in an inappropriate surgical approach being used initially for its removal (transsphenoidal). Thus, nonvisualization of the diaphragma sellae and elevated prolactin levels do not exclude a nonpituitary origin of a sellar-parasellar tumor. Other methods for preoperative differentiation are discussed.     

Characteristic MR imaging findings of cavernous hemangiomas in the cavernous sinus

Cavernous hemangiomas occur very rarely in the cavernous sinus and are difficult to diagnose preoperatively. MR images obtained in five patients with surgically verified cavernous hemangiomas in the cavernous sinus were reviewed. MR images showed hypointensity on T1-weighted images and well-defined hyperintensity on T2-weighted images with marked homogeneous enhancement after contrast material administration. We report the characteristic MR imaging observations for these lesions.     

Cavernous sinus invasion by pituitary adenoma: MR imaging

PURPOSE: To define magnetic resonance (MR) imaging criteria for the diagnosis of cavernous sinus invasion by pituitary adenoma. MATERIALS AND METHODS: The MR images obtained in 106 patients (86 female, 20 male; age range, 16-71 years) were reviewed retrospectively by two physicians. The standard-of-reference criteria for invasion were the surgical findings. A chi(2) analysis was performed, and the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for nine groups of MR imaging signs were computed. RESULTS: Invasion of the cavernous sinus was certain (PPV, 100%) if the percentage of encasement of the internal carotid artery (ICA) by tumor was 67% or greater. It was highly probable if the carotid sulcus venous compartment was not depicted (PPV, 95%) or the line joining the lateral wall of the intracavernous and supracavernous ICAs was passed by the tumor (PPV, 85%). It was definitely not invaded (NPV, 100%) if the percentage of encasement of the intracavernous ICA was lower than 25% or the line joining the medial wall of the intracavernous and supracavernous ICAs was not passed by the tumor. CONCLUSION: The radiologic diagnosis of cavernous sinus invasion by pituitary adenoma remains difficult, but the above-mentioned criteria may be of assistance.     

MR imaging of blood flows in the cavernous sinus

To evaluate blood flows in the cavernous sinus (CS), seven normal CSs and a postmortem CS were evaluated using T1-weighted spin echo sequences. After the noncontrast study, contrast study with Gd-DTPA was performed in all cases except the postmortem one. In the normal CSs, arterial flows of the intracavernous carotid artery (ICA) were disclosed as no-signal areas in the noncontrast study and were not enhanced with Gd-DTPA. Most venous flows in the CS were seen as low-intensity areas in the noncontrast study and were markedly enhanced with Gd-DTPA. However, these low-intensity areas were heterogeneous in intensity and several were higher and lower in intensity compared with most venous spaces. In the postmortem case, the CS showed homogeneous low intensity due to the stasis of blood flow. It was thought that the heterogeneous appearance of venous spaces in the normal CSs was due to flow-related phenomena. This heterogeneous pattern of signal intensity suggested the distribution of flow velocities. MR demonstrated both arterial and venous flows, and this was facilitated by Gd-DTPA. MR is a promising modality for the demonstration of blood flows in the CS.     

Cavernous sinus invasion by pituitary adenomas

One hundred ninety-eight surgically explored pituitary adenomas were evaluated preoperatively by high-resolution computed tomography (CT). At surgery, evidence of direct cavernous sinus invasion was demonstrated in 19. CT findings in these cases included cavernous sinus expansion (17 patients) and visible encasement of the internal carotid artery (14 patients). The invasive tumor often enhanced to a lesser degree than the cavernous sinuses and ipsilateral internal carotid artery. Intracavernous cranial nerve compression, obliteration, or displacement (14 patients), invasion of the lateral wall of the cavernous sinus (seven patients), and diffuse bone destruction (seven cases) were other findings. Magnetic resonance imaging in three patients provided excellent demonstration of intracavernous internal carotid artery encasement, but displacement and obliteration of intracavernous cranial nerves was not shown as well as it was with CT. Histologically, only three patients showed anaplastic features and only one of them had distant metastases. There was no correlation between histologic features, hormone assays, and invasiveness. This experience indicates any type of pituitary adenoma, regardless of its endocrinologic activity, can invade the cavernous sinus. Cavernous sinus involvement makes complete surgical removal difficult. Preoperative recognition of invasive behavior of these tumors has prognostic value and aids in designing appropriate management. CT is the most useful technique generally available for evaluation and follow-up.     

Gd-DTPA enhanced high resolution MR imaging of pituitary adenomas

Thirty-eight patients with surgically or biochemically confirmed pituitary adenomas were examined on a 1.5 T MRI system by means of spin echo technique with 3 mm slice thickness. T1 weighted sagittal and coronal sections were obtained before and after the administration of Gd-DTPA. Compared with the normal pituitary anterior lobe, 8% of the adenomas were hyperintense, 45% were isointense, 42% were hypointense and 5% were inhomogeneously intense. After Gd-DTPA administration, 13% enhanced to a greater degree, 10% to the same, and 57% to a lesser degree than the normal pituitary tissue. Twenty percent showed inhomogeneous enhancement. In 10%, there was evidence of adenoma only in the enhanced images. The delineation of the adenoma from the cavernous sinus was improved from 47% in unenhanced scans to 91% after Gd-DTPA administration.     

Dynamic enhancement features of cavernous sinus cavernous hemangiomas on conventional contrast-enhanced MR imaging

BACKGROUND AND PURPOSE: The reported MR imaging characteristics of cavernous sinus cavernous hemangiomas (CSCHs) in the literature are nonspecific. The purpose of our study was to explore dynamic enhancement features of CSCHs on conventional contrast-enhanced MR imaging and to correlate these features with histopathologic subtypes.MATERIALS AND METHODS: Twenty-one patients (8 male and 13 female; age range, 13–63 years; average age, 42.6 years) with surgically confirmed CSCHs were retrospectively investigated. Preoperative MR study was performed in all cases, consisting of T1-weighted axial imaging, T2-weighted axial imaging, T1-weighted sagittal imaging, and contrast-enhanced T1-weighted axial, sagittal, and coronal images.RESULTS: There were 4.8% (1/21) that showed homogeneous enhancement on all 3 contrast-enhanced sequences, whereas 95.2% (20/21) demonstrated heterogeneous enhancement on the first contrast-enhanced sequence. Among the 20 lesions, on subsequent contrast-enhanced sequences, 55.0% (11/20) showed homogeneous enhancement, whereas 35.0% (7/20) of lesions showed progressive contrast “filling in.” The remaining 10% (2/20) exhibited no apparent enhancement changes. The 95.2% (20/21) of lesions with heterogeneous enhancement on the first contrast-enhanced sequence correlated with type B or type C pathologic findings, whereas 4.8% (1/21) with homogeneous enhancement correlated with type A pathologic findings. Among the 20 type B or type C lesions, 80% (16/20) achieved total or near-total resection.CONCLUSION: Progressive contrast “filling in” in the tumors on conventional contrast-enhanced MR images can aid in differentiating between cavernous sinus lesions and suggest the diagnosis of cavernous hemangiomas.

Cavernous sinus cavernous hemangiomas (CSCHs) are rare vascular malformations, accounting for less than 1% of all parasellar masses.^1,2 Because of their tendency to bleed profusely during surgery, CSCHs require a different surgical approach and technique.^3–5 However, the rate of misdiagnosis is as high as 38.9%.⁶ Although the primary diagnostic tool for CSCHs is MR imaging, there are only scattered reports on their MR characteristics in the literature. The value of these reported MR characteristics is limited in diagnosis and differential diagnosis. However, as a specific characteristic of cavernous hemangiomas in extracranial organs, contrast “filling in” with CSCHs on dynamic MR imaging or CT has not been studied up to now. Our paper is a retrospective review of 21 patients with CSCHs surgically treated at our institution from 2001 through 2007, with particular focus on exploring new MR diagnostic characteristics for this lesion.     

MR imaging of dural AV fistulas at the cavernous sinus

The magnetic resonance appearance of dural arteriovenous fistulas (AVFs) at the cavernous sinus (CS) was studied in six angiographically verified cases. Magnetic resonance clearly demonstrated shunted blood as an area of signal void both in the CS and in the superior ophthalmic vein. The relationship between shunted blood, internal carotid artery, and extraocular nerves, as well as proptosis, enlargement of the extraocular muscles, and bulging of the lateral wall of the CS were also depicted in the images. Normal venous flow in the involved CS was shown as a low signal area that enhanced after gadolinium administration. Magnetic resonance is useful for screening and follow-up examinations of dural AVFs at the CS. It is essentially a noninvasive procedure that may be repeated and obviates the need for follow-up angiography. However, it should be noted that a signal void in the CS sometimes represents normal venous flow. A definite diagnosis should rely on angiography, which is essential for therapeutic planning.     

MR imaging of pituitary adenomas after gamma knife stereotactic radiosurgery

OBJECTIVE: The purpose of this study was to evaluate the response of pituitary adenomas to radiosurgery as manifested by changes in size and appearance on serial MR imaging. MATERIALS AND METHODS: Over a mean follow-up period of 36 months, changes in 44 pituitary adenomas were assessed on 147 enhanced MR imaging studies. Prior surgery had been performed in 36 tumors (82%). RESULTS: At the time of radiosurgery, mean tumor volume was 5.9 +/- 0.8 cm(3) (mean diameter, 2.2 cm). The mean reduction in volume at last follow-up was 41% (+/- 5%, p < 0.001), and a decrease in tumor volume of 25-100% was observed in 34 tumors (77%). Mean reduction in tumor volume at 6 months after radiosurgery was 9% (p = 0.095); at 1 year, 24% (p < 0.001); at 2 years, 34% (p < 0.001); at 3 years, 41% (p < 0.001); and at 4 years, 50% (p = 0.008). Six months after radiosurgery a slight and transient increase in size was observed in 21% of tumors. During follow-up, neither decreased contrast enhancement nor cyst development was associated with changes in tumor volume. CONCLUSION: Tumor control was observed for most pituitary adenomas after radiosurgery and occurred gradually over a period of several years. A small increase in tumor size might be observed in the first 6 months after radiosurgery. In most cases, reductions in tumor size were not accompanied by a change in contrast enhancement or cyst formation.     

MR imaging features of thyrotropin-secreting pituitary adenomas at initial presentation

OBJECTIVE: We report the MR imaging characteristics of thyrotropin-producing pituitary adenomas at their initial presentation and also report the role of MR imaging in predicting surgical outcome in these rare tumors. MATERIALS AND METHODS: We reviewed the records and MR images of 21 patients with thyrotropin-producing pituitary adenomas from 1984 to 1999. The imaging features of these tumors were examined, including enhancing characteristics and tumor volumes. A staging system of tumor invasion was designed by grading cavernous and sphenoid sinus invasion and suprasellar extension. A cumulative invasion score was then used as a predictor of short-term surgical outcome. RESULTS: Twenty patients had macroadenomas, and one patient had a microadenoma. In 17 of 21 patients, the thyrotropin-producing pituitary adenoma was clearly visualized as a hypoenhancing mass compressing the normal pituitary gland. Conversely, in four patients, the pituitary gland was not discernible because of complete distortion by the adenoma. Thyrotropin-producing pituitary adenomas were large and showed a tendency to invade surrounding structures. Tumor volume ranged from 0.42 to 94.2 cm(3) (mean +/- SD, 16.0 +/- 17.8 cm(3)). The mean score of tumor invasion was 4.77 +/- 2.06 of a maximal possible value of 9.0. A high staging score was found to be predictive of an unfavorable response to surgery. CONCLUSION: Thyrotropin-producing pituitary adenomas are usually large tumors at initial presentation with hypoenhancing features compared with normal pituitary tissue; they tend to be invasive. Greater amounts of invasion correlate with incomplete surgical removal of the tumor and continued hormonal secretion.     

MR imaging of pituitary adenomas treated with the prolactin inhibitor quinagolide

Purpose: To evaluate the volume of micro- and macroadenomas in quinagolide-treated patients with resistance to or intolerance of bromocriptine.Material and Methods: The effect of the prolactin inhibitor quinagolide on the volume of pituitary adenoma was evaluated retrospectively in 11 female patients. Prolactin levels before and after the treatment were also recorded. The indications for quinagolide therapy were side-effects of bromocriptine in 5 cases, a poor response to bromocriptine in 5 cases and both in 1 case. MR imaging with a 1.0-T magnet was performed to determine the volume reduction of the adenomas.Results: The average volume reduction of macroadenomas was 324 mm³ (46%) and that of microadenomas 73 mm³ (57%). The level of prolactin secreted by macroadenomas was reduced by an average of 163 μg/l (65%) and that by microadenomas of 113 μg (73%). In 2 microadenomas and in 1 macroadenoma, signal intensity changed during the treatment in T1-weighted images. In follow-up no changes in signal intensity were seen in 8 adenomas in non-contrast T1-weighted images. A haemorrhagic lesion was seen in 1 macroadenoma before treatment, but it disappeared during treatment.Conclusion: Quinagolide was found to be an effective alternative to bromocriptine in cases with drug intolerance or resistance, and MR imaging a suitable method for the follow-up of macro- and microadenomas.     

Magnetic resonance imaging of cavernous sinus cavernous hemangiomas

Summary Radiological findings of surgically verified cavernous hemangiomas of the cavernous sinus are presented with special reference to the appearance in magnetic resonance imaging. Differences in radiological features of the cavernous sinus cavernous hemangiomas and intracerebral cavernous hemangiomas are discussed.     

MR imaging of pituitary adenomas using a prototype resistive magnet: preliminary assessment

Magnetic resonance (MR) images were obtained with a prototype resistive magnet system in 10 patients, all of whom had been shown to have pituitary tumors by enhanced high-resolution computed tomography (CT). Histologic verification was obtained in eight cases. Inversion-recovery (IR) T1-weighted images revealed the tumor in six of nine cases; saturation-recovery (SR) images with less T1 weighting identified seven of nine tumors; Carr-Purcell-Meiboom-Gill (CPMG) spin-echo T2-weighted images revealed two of four tumors. MR images failed to demonstrate three microadenomas: 5 X 5 X 8 mm, 6 X 6 X 6 mm, and one less than 5 mm in estimated size. In the last pretreatment study, CT had demonstrated a 13 mm maximum diameter adenoma. Repeat CT at the time of MR imaging also showed a partially empty sella and did not resolve the residual adenoma. The larger adenomas were identified readily by MR imaging, which, unlike CT, suggested old tumor hemorrhage in two cases, which was confirmed at surgery and histologic examination. MR and CT images were also compared for relative effectiveness in identifying important perisellar structures.     

海绵窦侵袭型垂体瘤磁共振诊断系统及其相关因素分析

目的：探讨MR对海绵窦侵袭型垂体瘤的诊断价值，寻求建立一套海绵窦侵袭型垂体瘤的MR诊断系统。方法：选取手术中已经确诊的39例海绵窦侵袭型垂体瘤，同期162例非侵袭型垂体瘤做对照，应用计算机分析冠状位MR上肿瘤与海绵窦的关系。包括海绵窦形态的改变、窦内间隙的改变以及肿瘤与颈内动脉海绵窦段的关系等。将相关的各个类型均做为拟诊标准分别计算各自的灵敏度(Se)、特异度(Sp)、阳性预告值(PV )、阴性预告值(PV-)。依据医学统计学原理中的判别分析法进一步系统分析MR图像对于是否海绵窦侵袭型垂体瘤的诊断意义。结果：肿瘤包绕颈内动脉≥70％确诊侵袭的意义最大(PV ，100％)，肿瘤超过颈内动脉外侧连线的诊断意义也较高(PV ，86．1％)；如果肿瘤包绕颈内动脉的角度不到20％、肿瘤未超过颈内动脉内侧连线以及海绵窦内侧间隙未出现肿瘤则可以排除海绵窦侵袭的存在。同时应用判别分析法建立了一个海绵窦侵袭型垂体瘤及非海绵窦侵袭型垂体瘤的统计学判别计量数值表。从而完善了海绵窦侵袭型垂体瘤MR图像诊断系统。结论：通过系统分析垂体瘤加RI的表现，能够比较准确的确立海绵窦侵袭型垂体瘤的诊断。     

Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging

A dynamic study of magnetic resonance (MR) imaging was used to obtain successive heavily T1-weighted coronal images (spin-echo [SE] 100/15 [repetition time msec/echo time msec]) of normal pituitary glands and pituitary adenoma immediately after patients were given an intravenous bolus injection of gadopentetate dimeglumine. The images were obtained every minute for 5-8 minutes at 1.5 T. Usual T1-weighted images (SE 600/15) were also obtained before and after the dynamic study was performed. The study group consisted of 18 patients, 10 with normal pituitary glands, and eight with pituitary adenoma. Normal pituitary glands showed maximum enhancement on the first or second image following the administration of gadopentetate dimeglumine, followed by gradual signal reduction through the later images, whereas pituitary adenomas reached a peak of enhancement later and showed slower signal reduction than normal pituitaries. The difference of enhancement patterns between the normal pituitary gland and the pituitary adenoma produced prominent image contrast on the first or second image after administration of gadopentetate dimeglumine, which improved the visualization of one microadenoma and four normal pituitary glands that had been displaced by large adenomas. Dynamic MR imaging is a useful diagnostic procedure not only for detection of microadenomas, but also for visualization of pituitary glands that have been displaced by large pituitary adenomas.     

Magnetic resonance imaging of pituitary adenomas

Today, MR is the only method needed for the morphological investigation of endocrine-active pituitary adenomas. In acromegaly and Cushings syndrome, the therapeutic attitude is directly dictated by MR data. We present the MR aspect of pituitary adenomas according to size, sex, age, endocrine activity and a few particular conditions such as hemorrhagic pituitary adenomas, pituitary adenomas during pregnancy, cavernous sinus invasion and postsurgical changes. When an intrasellar mass extending out of the sella turcica is detected, the goal of the MR examination is to indicate precisely the origin of the tumor, its extension in relation to the various surrounding structures, its structure and its enhancement in order to help in the differential diagnosis. Demonstration of very small pituitary adenomas remains a challenge. When SE T1- and Turbo SE T2-weighted sequences are non-diagnostic, enhanced imaging becomes mandatory; half-dose gadolinium injection, delayed sequence, dynamic imaging can be of some help.     

Diagnosis of small and micro pituitary adenomas by intercavernous sinus venography

Summary Intercavernous sinuses surround the pituitary gland and their form can be modified by small pituitary tumors. A preliminary report of the use of venography for the diagnosis of pituitary microadenomas is presented.